Extended Treatment in Metastatic Breast Cancer With Eribulin

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Breast Cancer
Trial Locations (21)

Unknown

Santiago de Compostela

Las Palmas de Gran Canarias

San Sebastián

Barbastro

Alcorcón

Aravaca

Pozuelo de Alarcón

Pamplona

Bilbao

Badajoz

Cáceres

Jaén

Lleida

Madrid

Málaga

Murcia

Ourense

Salamanca

Seville

Valencia

Zaragoza

All Listed Sponsors
lead

Eisai Limited

INDUSTRY

NCT02769364 - Extended Treatment in Metastatic Breast Cancer With Eribulin | Biotech Hunter | Biotech Hunter